P4.3 Disease outcomes: What matters to whom as AD progresses? Relevant outcomes in disease progression Michael Smith: Important outcomes of Alzheimer’s disease from the perspective of people with the disease, their supporters & health professionals
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.